News from the healthcare data industry
CAMBRIDGE, Mass., June 10, 2024 /PRNewswire/ — ConcertAI, the leader in oncology predictive and generative AI SaaS Solutions and Real-World Data for healthcare and life sciences, today announced that Timothy (Tim) Albury has joined...
CAMBRIDGE, Mass., June 2, 2024 /PRNewswire/ — ConcertAI, the leading oncology real-world evidence data and AI SaaS technology company, today announced a collaboration with NVIDIA to advance a broad set of translational...
Solutions enable both research and clinical teams with precision oncology, accelerating clinical trials, increasing patient access, and driving improved patient outcomes CAMBRIDGE, Mass., May 31, 2024 /PRNewswire/ — ConcertAI, a leader in oncology...
New Clinical AI care suites for Cardiology, Pulmonology, and Neurology; First-in-Class multi-modal predictive and Gen AI platform for research and clinical model development. CAMBRIDGE, Mass., Feb. 26, 2024 /PRNewswire/ — ConcertAI‘s TeraRecon, the...
Leading cancer epidemiologist with long academic and industry career to lead regulatory and registry practice in oncology and hematology CAMBRIDGE, Mass., Jan. 30, 2024 /PRNewswire/ — ConcertAI, the leader in oncology Real-World Data...
Ryan Kennedy brings over 20 years’ experience leading technical innovation in the clinical research industry CAMBRIDGE, Mass., Jan. 24, 2024 /PRNewswire/ — ConcertAI, the leader in oncology predictive and generative AI SaaS Solutions...
Introduced CARA™, the predictive and generative AI Platform powered by multi-modal Real-World Data, enabling precision oncology, accelerating clinical trials, increasing patient access, driving improved patient outcomes. CAMBRIDGE, Mass., Jan. 11, 2024 /PRNewswire/...
Agreement enables AbbVie to leverage ConcertAI and Caris’ extensive clinical and genomic databases, coupled with Artificial Intelligence and Machine Learning (AI/ML)-derived insights to accelerate drug discovery, clinical development and precision...
CAMBRIDGE, Mass., Jan. 8, 2024 /PRNewswire/ — ConcertAI, LLC, a leading oncology real-world evidence data and AI technology company, and NeoGenomics, Inc., a leading oncology testing services company, today announced a broad...
ConcertAI will invest in CancerLinQ to provide its members with upgraded quality reporting, industry-leading real-world data, and AI-powered solutions for accelerated clinical trials in a multi-year cooperation agreement with ASCO...